Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks

Схожие документы

• Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality
  по: Eurich, Dean T, et al.
  Опубликовано: (2009)
• Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review
  по: Eurich, Dean T, et al.
  Опубликовано: (2007)
• Analyzing composite outcomes in cardiovascular studies: traditional Cox proportional hazards versus quality-of-life–adjusted survival approaches
  по: Eurich, Dean T, et al.
  Опубликовано: (2010)
• A cluster randomized trial to assess the impact of opinion leader endorsed evidence summaries on improving quality of prescribing for patients with chronic cardiovascular disease: rationale and design [ISRCTN26365328]
  по: Majumdar, Sumit R, et al.
  Опубликовано: (2005)
• Controlling the Ischemic Heart Disease Epidemic: Strategies for the 21st Century
  по: Majumdar, Sumit R., et al.
  Опубликовано: (2001)